Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Rachel Sim receives her poster prize at ChemBiOx2019

Congratulations to Rachel Sim, a DPhil student in the Russell lab, who was awarded the penultimate year poster prize at the chemical biology conference ChemBiOx 2019, held recently in Oxford.

Rachel, who is funded by the Agency of Science, Technology and Research (A*STAR), presented her work on developing affinity and fluorescent probes to elucidate the mechanism of small molecule modulators of neurogenesis.

Similar stories

EMA approval of IntraBio’s Aqneursa marks a major milestone for the Department of Pharmacology, with further Phase 3 success in Ataxia Telangiectasia

On 21 January, the European Medicines Agency (EMA) approved Aqneursa, a new treatment for Niemann-Pick Disease Type C (NPC) in adults and children, marking a major milestone for research originating in the Department of Pharmacology. Aqneursa already received US FDA approval (September 2024), enabling patient access on both sides of the Atlantic.